Ibn Al Haytham Hospital Co.

Ibn Al Haytham Hospital Co. has recently experienced a change in its valuation classification, now categorized as expensive. Key financial metrics include a P/E ratio of 0.00, an EV to EBIT of 9.27, and a return on capital employed of 1.94%. The stock has returned 18.84% over the past year.

Ibn Al Haytham Hospital Co. has experienced a recent evaluation adjustment, resulting in a below-average quality score. This change is linked to declining sales growth and significant drops in EBIT growth, alongside low returns on capital employed and equity. The stock is considered expensive relative to its valuation metrics.